-
Hospira Issues a Voluntary Nationwide Recall for Two Lots of Naloxone Hydrochloride Injection, USP, in the Carpuject™ Syringe System due to the Potential Presence of Particulate Matter
-
Now Available: Update in Osteoarthritis SAE-P
-
Reminder: MIPS Preliminary Performance Feedback Data Is Available
-
Submit Your Late-Breaking Research Abstracts by June 30
-
2016 Performance Scores are Now Available in the Physician Compare Downloadable Database
-
BCBS Michigan Cancels Modifier 25 Payment Adjustment
-
Meet Your MIPS Requirements with the Academy’s Registry
-
New Research: Many patients treated for head injuries do not receive follow-up care, study indicates
-
AAPM&R Members in the News: May 2018
-
The Value of Your #AAPMR2018 Registration
-
Just Announced: 2018 PhyzTalk Finalists
-
May Coding Q&A: If a Patient is Being Seen for a New Problem, Should They be Billed as a New Patient?
-
Congratulations to 2018 AAPM&R Award Recipients
-
June 7: Virtual Town Hall for IRF Proposed Rule
-
Naomi Lynn Gerber, MD, FAAPMR, to Receive Prestigious Frank H. Krusen, MD, Lifetime Achievement Award
-
Apotex Corp. Issues Voluntary Nationwide Recall of Piperacillin and Tazobactam For Injection, USP 3.375 Gram/Vial And 4.5 Gram/Vial Strengths Due to Elevated Levels of Impurities That May Result in Decreased Potency
-
Book Your Hotel Room for the 2018 Annual Assembly
-
Introducing the Refreshed Certification Qbank
-
Auromedics Pharma LLC Issues Voluntary Nationwide Recall of Product Piperacillin and Tazobactam For Injection 3.375 Grams Per Vial, Due to Presence of Glass Particulates
-
An Update from the Academy Leadership Program Fellows